Home/Filings/4/0001011240-03-000099
4//SEC Filing

JOHNSON ALAN G 4

Accession 0001011240-03-000099

CIK 0000057055other

Filed

Oct 20, 8:00 PM ET

Accepted

Oct 21, 3:42 PM ET

Size

14.1 KB

Accession

0001011240-03-000099

Insider Transaction Report

Form 4
Period: 2003-10-17
JOHNSON ALAN G
DirectorSr. V.P. & Sec.
Transactions
  • Exercise/Conversion

    Class B Common

    2003-10-17$7.04/sh+63,437$446,279161,312 total
  • Exercise/Conversion

    Incentive Stock Option (Right to Buy)

    2003-10-17$3.23/sh3,375$10,8916,750 total
    Exercise: $3.23From: 1996-11-06Exp: 2006-11-06Class A Common (3,375 underlying)
  • Exercise/Conversion

    Class A Common

    2003-10-17$3.23/sh+3,375$10,891192,405 total
  • Tax Payment

    Class A Common

    2003-10-17$23.91/sh68,289$1,632,790124,116 total
  • Exercise/Conversion

    Incentive Stock Option (Right to Buy)

    2003-10-17$6.79/sh90,030$610,85422,470 total
    Exercise: $6.79From: 1999-10-13Exp: 2004-10-13Class A Common (90,030 underlying)
  • Exercise/Conversion

    Class A Common

    2003-10-17$6.79/sh+90,030$610,854189,030 total
  • Exercise/Conversion

    Incentive Stock Option (Right to Buy)

    2003-10-17$7.04/sh63,437$446,27949,063 total
    Exercise: $7.04From: 1999-10-13Exp: 2004-10-13Class B Common (63,437 underlying)
  • Tax Payment

    Class B Common

    2003-10-17$24.08/sh15,625$376,250145,687 total

Issuer

KV PHARMACEUTICAL CO /DE/

CIK 0000057055

Entity typeother

Related Parties

1
  • filerCIK 0000941472

Filing Metadata

Form type
4
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 3:42 PM ET
Size
14.1 KB